6533b824fe1ef96bd1281076

RESEARCH PRODUCT

The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE–/–Mouse Model

Silvio BuscemiAe DearRw SimpsonTa GaspariI WelungodaRe WiddopLm KnudsenM. Mancuso

subject

Settore MED/09 - Medicina InternaAtherosclerosis liraglutide plaque mouseSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSettore MED/13 - Endocrinologiahttp://hdl.handle.net/10447/84865